Desperate Hacker

Chapter 616 Competition and Cooperation

There is no end to the road, and clinical trials that seem to be difficult can actually be easily started in India.

This simply subverted Liu Yiqing's long-held understanding.

But after she stayed in India for a few days and got to know the situation in this country. She had to sigh. Sure enough, there is a reason why the world allows India, a strange country, to have generic drugs that benefit the poor.

After all, it is a country that has joined the WTO. It is really unjustifiable that it does not respect intellectual property rights and is not sued and bankrupted by those old imperialist countries. Along with the waves of sanctions.

But the real truth is that India has liberalized its application for clinical trial licenses. Simply put, foreign pharmaceutical companies can also come to India to conduct clinical trials, and many poor people in India have become their experimental drugs. people.

It is precisely because of these cheap drug testers that foreign pharmaceutical giants turn a blind eye to this country's generic drugs.

In some ways, it's a compromise and an exchange.

The price is the lives of the lowest people in this country.

……

As for the source of funding, it seems that apart from the generous donation from the founder of the fund, the most likely source of funding is the new treatment developed by Professor Yamanaka.

……

……

……

However, in this step, it seems that there are still some complicated and difficult problems that need to be solved urgently.

But understanding these big principles right now is of little use to Liu Yiqing.

In fact, India's science and engineering fields are pretty good. At least three of its Nobel Prize winners are winners of awards other than literature and economics.

Her job is to keep the cancer research center running and fully funded.

When Professor Yamanaka stays here, he will inevitably be invited to participate in some academic activities.

Professor Yamanaka now has another stopover in his busy schedule, which is Mumbai, India.

According to Professor Yamanaka's idea.

Liu Yiqing stayed here and was responsible for the production connection with Sun Pharmaceutical Group.

Some things look beautiful, but there will never be good without reason in this world. It is more about benefits and equivalent exchange.

However, even if animal experiments are done thousands of times, they are not as valuable as one human experiment.

Although India has so far had more Nobel Prize winners than China, which is also a populous country.

Nobel Prize winners are still considered rare here in India.

The stem cells will then divide themselves after receiving nutrients and replace the damaged cells, thereby repairing the internal organs.

His method creates a biological patch that is applied to the outside of diseased organs using minimally invasive techniques.

However, the Indian Institute of Technology in Delhi is still eager for Professor Yamanaka.

After a few days of busy work, the preliminary cooperation has been reached. Next, Lin'an Research Center will send some assistants to assist in clinical trials.

As for the effect, there is no way to conduct objective analysis here. The final results and parameters still have to be sent back to Lin'an for further analysis and interpretation.

But just when they had just finished handling the matters at hand, they were about to leave. The American team that competes with them has also sent people here to produce their latest new type of super antibiotic.

This antibiotic is currently only controlled by the Cancer Research Fund in the United States. It is said to have a strong effect against some stubborn and drug-resistant bacteria.

However, both parties regretfully missed this opportunity for communication.

Because just when they arrived in Mumbai, Liu Yiqing and the others were about to leave.

In the hotel, Wang Ziran and Liu Yiqing also met.

The two had met once before in Malaysia, where there was another woman, and Annie Yang was also involved.

However, although they are currently in a competitive relationship, they are not at war with each other.

Both sides have achieved certain achievements in recent times.

Now that both sides are well, everyone's starting line is still the same. Both of them know their purpose, which is to develop a solution to Chen Qingfeng's physical illness.

But so far, their research can't say what it has to do with Chen Qingfeng's disease?
However, both of them seemed to realize at the same time that the research center might not be able to survive until the next year just relying on Chen Qingfeng’s donation.

Therefore, they are eager to transform some of their achievements into practical technologies.

"Congratulations, I heard that stem cell repair technology has made a breakthrough for diabetic patients!"

"We are all happy together. You are still very good. You have synthesized a brand new antibiotic. Not only did you get a new product, but you also found a new law and method..."

"By the way, are you interested in using our generative AI technology?"

"Of course I'm interested! But it seems that we don't have the funds to build a complete generative AI system here, and it is said that some key graphics cards are prohibited from being exported to the country!"

"Actually, this is also possible. If you feel it is safe, you can send the data over and we will share our large protein AI model with you in the cloud!"

When Liu Yiqing heard this suggestion, she thought it was very good.

But as their plane was about to take off, this conversation was destined to end in a hurry.

After the plane left Mumbai,
On the plane, Liu Yiqing told Professor Yamanaka the suggestion made by Wang Ziran.

"Are computers already so powerful? It's hard to imagine. But at my age, I no longer reject any technology. I don't think that only technology developed by people is a good technology. Whether it is a machine or a person, as long as it is developed by If your technology can solve practical problems, then that’s fine!”

"Professor, then you agreed to pass our data to them!"

"Why don't you agree! It is said that the two cancer research centers originally had the same funder. I think he was so generous in the first place and the purpose of the donation was to solve the cancer he suffered from as soon as possible!"

……

Sure enough, after experiencing so many things, Professor Yamanaka became more reasonable.

Liu Yiqing looked outside the plane at the scenery of clouds.

Suddenly, I couldn't help but think of many things.

We don’t know whether the birth of new technologies will bring more benefits or more disasters to mankind.

But it is inevitable that the technology world is currently undergoing an unprecedented tool change.

Not surprisingly, their research institute is the first research institution in China to use generative AI technology to assist research.

(End of this chapter)